Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-23

Clinical Trial Update: Efficacy and Safety of Latanoprost/Timolol for Primary Open Angle Glaucoma [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of latanoprost/timolol for primary open-angle glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • latanoprost/timolol

Snippet

Sponsor: Universiti Kebangsaan Malaysia Medical Centre | Conditions: Primary Open Angle Glaucoma | Phase 4 | Status: UNKNOWN